Terug
Ook genoteerd als
SDMHF
OTC
Dagbereik
€ 18,88
€ 20,08
52-Weeksbereik
€ 17,40
€ 26,54
Volume
144
50D / 200D Gem.
€ 22,02
/
€ 22,46
Vorige Slotkoers
€ 19,46
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 765,7 | 0,3 |
| P/B | 47,8 | 2,9 |
| ROE % | 6,3 | 3,7 |
| Net Margin % | 9,0 | 3,8 |
| Rev Growth 5Y % | -0,3 | 10,0 |
| D/E | 0,7 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
3 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
2,8 B | 0 |
Belangrijkste Punten
Revenue declined -0,32% annually over 5 years
Earnings grew 45,70% over the past year
Generating 139,66M in free cash flow
P/E of 765,74 — premium valuation
Groei
Revenue Growth (5Y)
-0,32%
Revenue (1Y)2,53%
Earnings (1Y)45,70%
FCF Growth (3Y)-28,45%
Kwaliteit
Return on Equity
6,32%
ROIC5,78%
Net Margin8,95%
Op. Margin18,50%
Veiligheid
Debt / Equity
0,67
Current Ratio1,02
Interest Coverage3,60
Waardering
P/E Ratio
765,74
P/B Ratio47,78
EV/EBITDA374,86
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,53% | Revenue Growth (3Y) | 1,34% |
| Earnings Growth (1Y) | 45,70% | Earnings Growth (3Y) | -9,24% |
| Revenue Growth (5Y) | -0,32% | Earnings Growth (5Y) | -11,42% |
| Profitability | |||
| Revenue (TTM) | 2,85B | Net Income (TTM) | 255,12M |
| ROE | 6,32% | ROA | 3,18% |
| Gross Margin | 45,33% | Operating Margin | 18,50% |
| Net Margin | 8,95% | Free Cash Flow (TTM) | 139,66M |
| ROIC | 5,78% | FCF Growth (3Y) | -28,45% |
| Safety | |||
| Debt / Equity | 0,67 | Current Ratio | 1,02 |
| Interest Coverage | 3,60 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 765,74 | P/B Ratio | 47,78 |
| P/S Ratio | 68,54 | PEG Ratio | -9,01 |
| EV/EBITDA | 374,86 | Dividend Yield | 0,00% |
| Market Cap | 195,35B | Enterprise Value | 197,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,85B | 2,78B | 2,78B | 3,49B | 2,89B |
| Net Income | 255,12M | 175,10M | 309,70M | 876,10M | 414,40M |
| EPS (Diluted) | 0,03 | 0,18 | 0,34 | 0,95 | 0,45 |
| Gross Profit | 1,29B | 1,21B | 1,23B | 1,82B | 1,55B |
| Operating Income | 527,33M | 370,60M | 484,50M | 1,08B | 683,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,01B | 8,26B | 7,74B | 5,07B | 3,95B |
| Total Liabilities | 3,89B | 4,23B | 5,07B | 2,55B | 2,22B |
| Shareholders' Equity | 4,09B | 3,99B | 2,64B | 2,45B | 1,66B |
| Total Debt | 2,75B | 2,87B | 3,68B | 1,14B | 625,52M |
| Cash & Equivalents | 425,92M | 678,90M | 116,60M | 107,10M | 223,63M |
| Current Assets | 1,44B | 1,74B | 1,42B | 1,67B | 1,46B |
| Current Liabilities | 1,41B | 938,80M | 937,30M | 1,04B | 1,04B |